Assessment of Bimodal Contribution in Adult Cochlear Implant Users

Status Recruiting

Clinical Trial Summary

To evaluate the combination of electric hearing through Cochlear Implant and acoustic hearing through hearing aid in bimodal users with moderate-to-severe hearing loss in the non-implanted ear. The research will also provide pilot study data on unilateral Cochlear Implant recipients with residual useful acoustic hearing in the implanted ear whose acoustic hearing has been preserved.

Clinical Trial Description

Many current unilateral Cochlear Implant users have some residual acoustic hearing in the opposite ear as well as in the implanted ear. The amount of useful residual acoustic hearing varies among these implantees. There are several acoustic and electric combinations in the bilateral-bimodal listening mode depending on the amount of useful residual acoustic hearing in each ear. The combination of low frequency acoustic information provided by the hearing aid on each ear, completes the high frequency electric information provided by the Cochlear Implant (complementary bimodal benefit). Each of the different rehabilitation combinationsfor unilateral Cochlear Implant users enablesa unique integration of the three aspects of bilateral hearing bilaterality, binaurality and bimodality which may provide significant advantages over unilateral Cochlear Implant stimulation in terms of speech perception in noise, complementary information as well as localization abilities.

The study will include 20 bilateral-bimodal users with moderate-to-severe hearing loss at 250 Hz, 500 Hz and 1000 Hz in the non-implanted ear, who use hearing aids for at least 75% of their waking hours. Evaluation utilizes bilateral-binaural and bimodal complementary effects task-specific test batteries based on published doctoral research project. The assessment protocol consisted of tests that include various speech materials, different maskers, presentation of the noise from different locations in space, right/left speech lateralization, pitch-related tasks and subjective questionnaires. All tests will be administered in three listening conditions: Cochlear Implant -alone, hearing aid-alone and Cochlear Implant +hearing aid. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Deafness

Clinical Trial Details

NCT number	NCT02331017
Study type	Interventional
Source	Bnai Zion Medical Center
Contact	Michal Luntz, MD
Phone	97248359544
Email	michal.luntz@b-zion.org.il
Status	Recruiting
Phase	N/A
Start date	December 2014
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05086809` - Investigation of an Updated Bone-anchored Sound Processor	N/A
Withdrawn	`NCT02890576` - Ambulatory Telemonitoring of People With Hearing Loss and Having a Cochlear Implant COCHLESURV
Completed	`NCT01256229` - Outcomes In Children With Developmental Delay And Deafness	Phase 1
Recruiting	`NCT04795986` - First Clinical Evaluation of HEARO Robotic Cochlear Implantation Surgery in Austria
Recruiting	`NCT05867173` - Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces	N/A
Completed	`NCT06104813` - Evaluation of Deaf Men's Knowledge About Sexual Health
Completed	`NCT04563884` - Validity of the French Version of Deafness Questionnaires for Children and Adolescents
Not yet recruiting	`NCT06088953` - EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER	N/A
Completed	`NCT03980808` - American Sign Language-Accessible Diabetes Education	N/A
Completed	`NCT03694340` - Optimization of Cochlear Implant MAP-parameters in Children	N/A
Terminated	`NCT01959152` - Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode	N/A
Completed	`NCT02539901` - Development of a Deaf Child With a Cochlear Implant.	N/A
Withdrawn	`NCT00604474` - Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants	N/A
Completed	`NCT00511381` - Genetic Testing in Detection of Late-Onset Hearing Loss	N/A
Terminated	`NCT03867058` - Tradeoff Between Spatial and Temporal Resolution
Completed	`NCT01109576` - Workshops for Veterans With Vision and Hearing Loss	Phase 0
Completed	`NCT01400178` - Cochlear Implants in Post-lingually Children: Results After 10 Years	N/A
Completed	`NCT04106063` - A New Speech, Spatial, and Qualities of Hearing Scale Short-Form for Deaf Children
Active, not recruiting	`NCT03352154` - Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants	N/A
Recruiting	`NCT04495660` - Restauration of the Auditory and Cognitive Functions in Cochlear Implanted Deaf Children in fNIRS	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.